Impact of blood eosinophil variability in asthma: a real-life population study. Source: Virtual Congress 2021 – Clinical features and new biomarkers of asthma, COPD and chronic cough Year: 2021
Clinical variables and protein biomarkers associated with blood eosinophil count and asthma in young adults Source: Virtual Congress 2021 – Clinical features and new biomarkers of asthma, COPD and chronic cough Year: 2021
Blood eosinophil level and lung function trajectories: cross-sectional and longitudinal studies in European cohorts Source: ERJ Open Res, 6 (4) 00320-2020; 10.1183/23120541.00320-2020 Year: 2020
Blood eosinophil counts in the general population and airways disease: a comprehensive review and meta-analysis Source: Eur Respir J, 59 (1) 2004590; 10.1183/13993003.04590-2020 Year: 2022
Characteristics of children with asthma and blood eosinophilia: an observational study Source: Virtual Congress 2021 – Biomarkers and risk factors in childhood asthma Year: 2021
The search for the “healthy” blood eosinophil count Source: Eur Respir J, 55 (5) 2000473; 10.1183/13993003.00473-2020 Year: 2020
Similar distribution of peripheral blood eosinophil counts in European and East Asian populations from investigations of large-scale general population studies: the Nagahama Study Source: Eur Respir J, 57 (1) 2004101; 10.1183/13993003.04101-2020 Year: 2021
Blood granulocyte patterns as predictors of asthma phenotypes in adults from the EGEA study Source: Eur Respir J 2016; 48: 1040-1051 Year: 2016
Alpha1-antitrypsin blood levels and lung function in the population-based SAPALDIA cohort Source: Eur Respir J 2005; 26: Suppl. 49, 219s Year: 2005
Blood eosinophil count in the general population: typical values and potential confounders Source: Eur Respir J, 55 (5) 1901874; 10.1183/13993003.01874-2019 Year: 2020
Longitudinal measurements of blood eosinophils in relation to COPD outcomes Source: International Congress 2018 – Clinical determinants and biomarkers of COPD Year: 2018
The blood eosinophil count as a biomarker in COPD Source: International Congress 2015 – Individualised risk reduction strategies for patients with COPD Year: 2015
The distribution of blood eosinophil count in the IMPACT South America population Source: Virtual Congress 2020 – COPD : inhaled corticosteroids, bronchodilators and eosinophils Year: 2020
Relationship between blood eosinophil count (Eos), clinical characteristics and mortality of patients with COPD Source: International Congress 2016 – Biomarkers and phenotypes of COPD and comorbidities Year: 2016
Low versus high Th2 asthma: variability of blood eosinophil counts in a longitudinal analysis Source: Virtual Congress 2021 – Severe asthma: evaluation using patient-reported outcome measures (PROMs) and biomarkers, comorbidities and treatments Year: 2021
Elevated baseline blood eosinophil count is related to greater lung function decline over 20-years of follow-up. Source: International Congress 2019 – Eosinophils and FeNO in airway diseases Year: 2019
Association between blood eosinophil counts and risk of rehospitalization in patients with asthma Source: International Congress 2017 – Monitoring novel biomarkers in asthma Year: 2017
Lack of seasonal variability of blood eosinophil counts in COPD Source: International Congress 2019 – Airway diseases and blood cells Year: 2019
Clinical significance of blood neutrophil differential count in patients with COPD Source: International Congress 2017 – Biomarker-based asthma control Year: 2017